Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment-Reference-Cited by-同舟云学术

Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment

Published:2024-04 Issue:4 Volume:63 Page:107107
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Amadesi Stefano^ORCID,Gatti Milo^ORCID,Rinaldi Matteo^ORCID,Pea Federico^ORCID,Viale Pierluigi,Gaibani Paolo^ORCID

Funder

Ministero della Salute

Publisher

Elsevier BV

Reference5 articles.

1. Resistance to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam in Gram-negative MDR bacilli: molecular mechanisms and susceptibility testing;Gaibani;Antibiotics (Basel),2022

2. Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam- based treatments;Gaibani;J Antimicrob Chemother,2022

3. Cefiderocol: Systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance;Karakonstantis;Antibiotics (Basel),2022

4. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke;Sacks;J Vasc Interv Radiol,2018

5. Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients;Gaibani;Clin Microbiol Infect,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibacterials;Reactions Weekly;2024-04-06